Cardiovascular & Respiratory Market Reports

  EP Devices: Percent Share of Conditions in EP Therapy, Global, 2021 The population prevalence of AFib is 2% to 3% in Europe and the United States. Treating the complications resulting from AFib accounts for 1% to 3% of healthcare expenditure. (Frost &...